Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | VHL |
Variant | C162Y |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | VHL C162Y lies within the Elongin BC complex-interacting region of the Vhl protein (UniProt.org). C162Y has been identified in the scientific literature (PMID: 23797736, PMID: 17264095), but has not been biochemically characterized and therefore, its effect on VHL protein function is unknown (PubMed, Apr 2024). |
Associated Drug Resistance | |
Category Variants Paths |
VHL mutant VHL C162Y |
Transcript | NM_000551.4 |
gDNA | chr3:g.10149808G>A |
cDNA | c.485G>A |
Protein | p.C162Y |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000551 | chr3:g.10149808G>A | c.485G>A | p.C162Y | RefSeq | GRCh38/hg38 |
NM_000551.3 | chr3:g.10149808G>A | c.485G>A | p.C162Y | RefSeq | GRCh38/hg38 |
NM_000551.4 | chr3:g.10149808G>A | c.485G>A | p.C162Y | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|